-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Emergent BioSolutions Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $27.6M.
- Emergent BioSolutions Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $39M, a 16.4% increase year-over-year.
- Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2023 was $29.3M.
- Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2022 was -$7.4M, a 109% decline from 2021.
- Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2021 was $83.7M, a 21.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)